132. Targeting ferroptosis cell death for cancer and beyond, Luba Greenwood, CEO, Kojin Therapeutics
Synopsis: Luba Greenwood is the CEO of Kojin Therapeutics and Managing Partner of Dana Farber Cancer Institute Venture Fund. Kojin Therapeutics harnesses groundbreaking discoveries in cell state and ...
21 Dec 202231min
131. Epigenetic approaches to rare diseases, Amber Salzman, CEO, Epic Bio
Synopsis: Amber Salzman is the CEO of Epic Bio, a company that develops therapies to dynamically control gene expression and treat complex diseases. Dr. Salzman started her career in big pharma at Gl...
14 Dec 202224min
130. Breast cancer: targeted treatment options, Sean Bohen, President & CEO, Olema Oncology
Synopsis: Sean Bohen is the President and CEO of Olema Oncology, a company dedicated to developing targeted therapies for women with breast cancer. An oncologist by training, Dr. Bohen has a backgro...
7 Dec 202222min
129. Progress in complex diseases: NASH, Long COVID, and beyond, Bill Hinshaw, Pres. & CEO, Axcella
Synopsis: Bill Hinshaw is the President and CEO of Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulat...
30 Nov 202226min
128. Treating rare neurological diseases & guiding mission, Jeremy Levin, Chairman & CEO, Ovid Tx
Synopsis: Jeremy Levin is the Chairman and CEO of Ovid Therapeutics, a company that develops medicines to treat patients with rare neurological conditions, including epilepsies and seizure-related di...
23 Nov 202230min
127. Immuno-oncology landscape, Keith Flaherty, Dir. of Clin. Research, Mass General Cancer Center
Synopsis: Keith Flaherty is the Director of Clinical Research at Mass General Cancer Center and a Professor of Medicine at Harvard Medical School. Dr. Flaherty is a medical oncologist and has worked ...
16 Nov 202247min
126. New frontier in biology: harnessing the power of the repeatome, Dennis Zaller, CSO, ROME tx
Synopsis: Dennis Zaller is the Chief Scientific Officer of ROME Therapeutics, a company developing novel therapies for cancer and autoimmune diseases by harnessing the power of the dark genome, defin...
9 Nov 202223min
125. Gene circuits for smarter medicine, Tim Lu, Co-Founder & CEO, & Kanya Rajangam, CMDO, Senti Bio
Synopsis: This episode is co-hosted by Chris Ghadban at BIOS Builders. Guests Tim Lu and Kanya Rajangam are the Co-Founder & CEO and Chief Medical and Development Officer, respectively, of Senti Bio...
2 Nov 202239min
